X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-18 | ELMD | Electromed, Inc. | Skarvan Kathleen | Dir | S - Sale | $28.01 | -150,000 | 81,383 | -65% | -$4,201,350 | |||||
| DM | 2024-11-15 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $20.70 | -42,604 | 284,442 | -13% | -$882,110 | |||||
2024-11-14 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $8.09 | -2,000 | 14,603,662 | 0% | -$16,180 | ||||||
2024-11-15 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $0.80 | -5,645 | 913,621 | -1% | -$4,516 | ||||||
2024-11-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $0.80 | -1,375 | 238,022 | -1% | -$1,100 | ||||||
2024-11-15 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $0.80 | -3,203 | 227,092 | -1% | -$2,562 | ||||||
2024-11-15 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $0.80 | -4,221 | 310,767 | -1% | -$3,377 | ||||||
2024-11-18 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $0.85 | -2,800 | 88,227 | -3% | -$2,380 | ||||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Greene James S | Dir | P - Purchase | $0.58 | +428,082 | 828,082 | +107% | +$250,000 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Dickson Daniel H | Dir | P - Purchase | $0.58 | +85,616 | 85,616 | New | +$50,000 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Katz Avi S | COB | P - Purchase | $0.58 | +3,142,122 | 3,329,192 | >999% | +$1,834,999 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Dinu Raluca | CEO | P - Purchase | $0.00 | +470,890 | 657,959 | +252% | +$0 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Weiner Zeev | Dir | P - Purchase | $0.58 | +85,616 | 85,616 | New | +$50,000 | |||||
| D | 2024-11-12 | QTI | Qt Imaging Holdings, Inc. | Taylor Ross | Dir | P - Purchase | $0.58 | +171,232 | 171,232 | New | +$99,999 | |||||
2024-11-12 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $26.34 | -91 | 107,756 | 0% | -$2,397 | ||||||
2024-11-12 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $26.34 | -66 | 157,225 | 0% | -$1,738 | ||||||
2024-11-12 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $26.34 | -123 | 317,046 | 0% | -$3,240 | ||||||
2024-11-12 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $26.19 | -147 | 123,347 | 0% | -$3,850 | ||||||
| M | 2024-11-07 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $8.93 | -10,000 | 14,605,662 | 0% | -$89,280 | |||||
| D | 2024-11-11 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $90.04 | -1,458 | 20,843 | -7% | -$131,278 | |||||
2024-11-08 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.26 | +3,968,253 | 18,373,169 | +28% | +$4,999,999 | ||||||
| D | 2024-11-07 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO | S - Sale+OE | $37.93 | -50,000 | 100,313 | -33% | -$1,896,500 | |||||
2024-11-07 | SMLR | Semler Scientific, Inc. | Semler Eric | Dir | P - Purchase | $37.93 | +50,000 | 699,492 | +8% | +$1,896,500 | ||||||
| D | 2024-11-05 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale+OE | $83.55 | -6,750 | 732 | -90% | -$563,994 | |||||
| M | 2024-11-04 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $8.51 | -6,000 | 14,615,662 | 0% | -$51,080 | |||||
| D | 2024-11-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $82.64 | -1,083 | 20,843 | -5% | -$89,499 | |||||
2024-11-01 | ZYXI | Zynex Inc | Moorhead Daniel J | CFO | S - Sale | $8.59 | -10,000 | 44,878 | -18% | -$85,900 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $23.15 | -203 | 60,700 | 0% | -$4,699 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $23.15 | -311 | 107,847 | 0% | -$7,200 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $23.15 | -277 | 157,291 | 0% | -$6,413 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.15 | -547 | 317,169 | 0% | -$12,663 | ||||||
2024-10-30 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $23.15 | -894 | 123,494 | -1% | -$20,696 | ||||||
| M | 2024-10-30 | ZYXI | Zynex Inc | Sandgaard Thomas | Pres, CEO, COB, 10% | S - Sale | $8.79 | -6,000 | 14,621,350 | 0% | -$52,740 | |||||
2024-10-28 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $2.19 | +500 | 148,293 | 0% | +$1,095 | ||||||
| DM | 2024-10-15 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $23.23 | -20,000 | 317,716 | -6% | -$464,500 | |||||
| D | 2024-10-15 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $132.71 | -8,625 | 531,002 | -2% | -$1,144,648 | |||||
| D | 2024-10-15 | CBLL | Ceribell, Inc. | Tpg Gp A, LLC | 10% | P - Purchase | $17.00 | +380,268 | 3,967,422 | +11% | +$6,464,556 | |||||
| D | 2024-10-15 | CBLL | Ceribell, Inc. | Tammenoms Bakker Juliet | Dir | P - Purchase | $17.00 | +237,234 | 2,481,728 | +11% | +$4,032,978 | |||||
| M | 2024-10-01 | VANI | Vivani Medical, Inc. | Dwyer Donald | Chief Business Officer | P - Purchase | $1.13 | +2,500 | 50,000 | +5% | +$2,835 | |||||
2024-10-01 | SLNO | Soleno Therapeutics Inc | Yen Kristen | SEE REMARKS | S - Sale | $49.43 | -3,108 | 81,465 | -4% | -$153,627 | ||||||
2024-10-01 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $49.43 | -8,077 | 119,172 | -6% | -$399,241 | ||||||
2024-10-01 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | SEE REMARKS | S - Sale | $49.43 | -3,108 | 108,932 | -3% | -$153,627 | ||||||
2024-10-01 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $49.43 | -21,633 | 719,553 | -3% | -$1,069,306 | ||||||
| D | 2024-10-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $148.24 | -2,958 | 20,843 | -12% | -$438,491 | |||||
| D | 2024-09-23 | GTHP | Guided Therapeutics Inc | Imhoff John E | Dir, 10% | P - Purchase | $0.00 | +1,666,667 | 7,075,898 | +31% | +$0 | |||||
| DM | 2024-09-18 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale+OE | $24.69 | -20,000 | 317,716 | -6% | -$493,700 | |||||
| M | 2024-07-18 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $24.16 | -603 | 157,568 | 0% | -$14,566 | |||||
| M | 2024-07-11 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $23.39 | -736 | 108,158 | -1% | -$17,214 | |||||
| M | 2024-07-11 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $23.32 | -767 | 317,716 | 0% | -$17,888 | |||||
| M | 2024-07-11 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $22.48 | -780 | 60,903 | -1% | -$17,536 | |||||
| M | 2024-07-11 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $22.77 | -1,581 | 124,388 | -1% | -$35,992 | |||||
2024-09-16 | BLFS | Biolife Solutions Inc | Richardson Garrie | Chief Revenue Officer | S - Sale | $25.12 | -3,070 | 114,773 | -3% | -$77,118 | ||||||
| D | 2024-09-16 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $153.42 | -8,625 | 531,002 | -2% | -$1,323,210 | |||||
2024-09-11 | LIVN | Livanova Plc | Bianchi Francesco | Dir | S - Sale | $46.58 | -1,500 | 8,772 | -15% | -$69,870 | ||||||
| AM | 2024-08-28 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO, 10% | S - Sale | $28.34 | -10,881 | 50,313 | -18% | -$308,389 | |||||
| D | 2024-09-03 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $159.60 | -2,960 | 20,843 | -12% | -$472,404 | |||||
| M | 2024-08-28 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $47.43 | -10,705 | 84,573 | -11% | -$507,745 | |||||
| M | 2024-08-28 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $47.43 | -13,531 | 127,249 | -10% | -$641,783 | |||||
| M | 2024-08-28 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $47.43 | -10,705 | 112,040 | -9% | -$507,745 | |||||
| M | 2024-08-28 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $47.43 | -115,004 | 741,186 | -13% | -$5,454,707 | |||||
| M | 2024-08-28 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO, 10% | S - Sale | $28.34 | -10,780 | 83,791 | -11% | -$305,540 | |||||
| M | 2024-08-27 | SLNO | Soleno Therapeutics Inc | Vivo Opportunity, LLC | 10% | S - Sale | $48.01 | -1,025,000 | 6,291,851 | -14% | -$49,210,750 | |||||
| D | 2024-08-27 | TMDX | Transmedics Group, Inc. | Corcoran Nicholas | See Remarks | S - Sale+OE | $176.02 | -10,000 | 21,105 | -32% | -$1,760,200 | |||||
| DM | 2024-08-21 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $173.24 | -45,000 | 531,002 | -8% | -$7,795,600 | |||||
| M | 2024-08-19 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $1.88 | +1,254 | 2,794,068 | 0% | +$2,358 | |||||
2024-08-15 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $1.90 | +8,095 | 2,792,814 | 0% | +$15,350 | ||||||
| M | 2024-08-16 | STRR | Star Equity Holdings, Inc. | Coleman Richard Kenneth Jr. | CEO | P - Purchase | $5.20 | +3,000 | 39,067 | +8% | +$15,600 | |||||
| D | 2024-08-15 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $169.73 | -8,625 | 531,002 | -2% | -$1,463,919 | |||||
2024-08-15 | ECOR | Electrocore, Inc. | Errico Thomas J. | Dir | P - Purchase | $6.12 | +5,000 | 233,818 | +2% | +$30,595 | ||||||
2024-08-16 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.05 | -2,746 | 91,027 | -3% | -$2,883 | ||||||
| E | 2024-08-15 | POCI | Precision Optics Corporation, Inc. | Lawande Mahesh | COO | P - Purchase | $5.79 | +1,726 | 1,726 | New | +$9,994 | |||||
| E | 2024-08-15 | POCI | Precision Optics Corporation, Inc. | Coll Wayne M | CFO | P - Purchase | $5.79 | +4,317 | 4,317 | New | +$24,995 | |||||
| E | 2024-08-15 | POCI | Precision Optics Corporation, Inc. | Forkey Joseph Norman | CEO | P - Purchase | $5.79 | +1,725 | 122,572 | +1% | +$9,988 | |||||
2024-08-15 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $0.84 | -5,308 | 919,266 | -1% | -$4,459 | ||||||
2024-08-15 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $0.84 | -1,293 | 239,397 | -1% | -$1,086 | ||||||
2024-08-15 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $0.84 | -3,011 | 230,295 | -1% | -$2,529 | ||||||
2024-08-15 | OM | Outset Medical, Inc. | Ahmed Nabeel | CFO | S - Sale | $0.84 | -3,971 | 314,988 | -1% | -$3,336 | ||||||
2024-08-13 | NXL | Nexalin Technology, Inc. | Owens David | Chief Medical Officer | P - Purchase | $0.95 | +1,000 | 147,793 | +1% | +$950 | ||||||
| DM | 2024-06-05 | TMDX | Transmedics Group, Inc. | Ranganath Anil P. | See remarks | S - Sale+OE | $149.81 | -4,992 | 8,893 | -36% | -$747,838 | |||||
2024-08-08 | TMDX | Transmedics Group, Inc. | Tobin James R | Dir | S - Sale | $159.33 | -20,000 | 175,071 | -10% | -$3,186,536 | ||||||
| M | 2024-08-06 | ZYXI | Zynex Inc | Lucsok Anna | COO | S - Sale | $8.02 | -24,875 | 16,980 | -59% | -$199,410 | |||||
| D | 2024-08-06 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale+OE | $149.96 | -6,750 | 732 | -90% | -$1,012,230 | |||||
| M | 2024-08-05 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $45.60 | -10,974 | 95,278 | -10% | -$500,398 | |||||
| M | 2024-08-05 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $45.60 | -14,983 | 140,780 | -10% | -$683,202 | |||||
| M | 2024-08-05 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $45.60 | -11,009 | 122,745 | -8% | -$501,994 | |||||
| M | 2024-08-05 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $45.60 | -127,344 | 856,190 | -13% | -$5,806,696 | |||||
| D | 2024-08-01 | TMDX | Transmedics Group, Inc. | Khayal Tamer I | Chief Commercial Officer | S - Sale+OE | $156.77 | -2,958 | 20,843 | -12% | -$463,727 | |||||
| M | 2024-07-30 | VANI | Vivani Medical, Inc. | Dwyer Donald | Chief Business Officer | P - Purchase | $1.24 | +9,000 | 47,500 | +23% | +$11,120 | |||||
2023-11-22 | VANI | Vivani Medical, Inc. | Dwyer Donald | Chief Business Officer | P - Purchase | $0.96 | +2,000 | 38,500 | +5% | +$1,920 | ||||||
| D | 2024-07-31 | ITGR | Integer Holdings Corp | Hobby Jean M. | Dir | S - Sale+OE | $119.66 | -11,960 | 2,280 | -84% | -$1,431,132 | |||||
2024-07-31 | ITGR | Integer Holdings Corp | Maxwell Martin C | Dir | S - Sale | $118.88 | -4,700 | 20,656 | -19% | -$558,724 | ||||||
2024-07-30 | ITGR | Integer Holdings Corp | Harris John A | EVP, Global Ops, Manufactur | S - Sale | $123.80 | -3,400 | 1,522 | -69% | -$420,920 | ||||||
2024-07-29 | ZYXI | Zynex Inc | Disbrow Joshua R. | Dir | P - Purchase | $8.32 | +7,000 | 72,000 | +11% | +$58,233 | ||||||
2024-07-30 | ZYXI | Zynex Inc | Moorhead Daniel J | CFO | S - Sale | $8.24 | -15,000 | 122,247 | -11% | -$123,600 | ||||||
2024-07-24 | OM | Outset Medical, Inc. | Nash Marc | SVP Operations, R, D | S - Sale | $4.02 | -723 | 240,690 | 0% | -$2,906 | ||||||
| D | 2024-07-15 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | S - Sale+OE | $145.17 | -8,625 | 531,002 | -2% | -$1,252,051 | |||||
2024-07-01 | SLNO | Soleno Therapeutics Inc | Yen Kristen | See Remarks | S - Sale | $41.54 | -2,170 | 21,252 | -9% | -$90,136 | ||||||
2024-07-01 | SLNO | Soleno Therapeutics Inc | Mackaness James H | CFO | S - Sale | $41.54 | -7,190 | 55,763 | -11% | -$298,654 | ||||||
2024-07-01 | SLNO | Soleno Therapeutics Inc | Hirano Patricia C | See Remarks | S - Sale | $41.54 | -2,170 | 48,754 | -4% | -$90,136 | ||||||
2024-07-01 | SLNO | Soleno Therapeutics Inc | Anish Bhatnagar | CEO | S - Sale | $41.54 | -19,256 | 133,534 | -13% | -$799,844 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |